MEI Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MEI Pharma generated cash of -$50,473,000, which is more than the previous year. Cash used in financing activities reached the amount of -$11,868,000 last year. Net change in cash is therefore -$13,201,000.
Cash Flow
| 2015 | -28.06M | -10.05M | 43.07M |
|---|---|---|---|
| 2016 | -17.85M | 9.97M | 0 |
| 2017 | 3.48M | -10.07M | 4.21M |
| 2018 | -21.30M | -44.32M | 70.48M |
| 2019 | -29.42M | 24.31M | 1.38M |
| 2020 | 34.25M | -106.29M | 74.77M |
| 2021 | -31.96M | 24.70M | 3.46M |
| 2022 | -48.74M | 6.89M | 49.05M |
| 2023 | -52.48M | 53.69M | -40K |
| 2024 | -50.47M | 49.14M | -11.86M |
0JW9.L Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 16.90M | 15.74M | 8.54M | 12.33M | 9.59M | 13.30M | 8.45M | 10.83M | 18.72M | 13.77M |
Operating activities | ||||||||||
Net income | 17.77M | -31.83M | -54.45M | -50.57M | -46.01M | -16.81M | -40.06M | 2.67M | -20.86M | -32.69M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 383K | 386K | 326K | 285K | 109K | 80K | 53K | 85K | 58K | 64K |
Stock-based compensation expense | 2.27M | 3.58M | 8.35M | 10.24M | 6.80M | 6.56M | 0 | 2.30M | 2.72M | 4.22M |
| Deferred income tax benefit | 2.27M | 3.58M | 8.35M | 10.24M | 6.80M | 6.56M | 0 | 2.30M | 2.72M | 4.22M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 85K | 9.95M | -2.46M | 15.69M | -2.34M | -199K | 0 | 0 | 0 | 0 |
Inventories | 0 | -9.95M | 2.46M | -15.69M | 2.34M | 199K | 0 | 0 | 0 | 0 |
Accounts payable | -3.14M | -1.78M | 1.56M | 3.91M | -2.35M | 1.14M | 3.05M | -494K | 216K | -845K |
Cash generated by operating activities | -50.47M | -52.48M | -48.74M | -31.96M | 34.25M | -29.42M | -21.30M | 3.48M | -17.85M | -28.06M |
Investing activities | ||||||||||
Purchases Of Investments | -58.23M | -101.76M | -272.65M | -420.15M | -190.27M | -64.65M | -114.23M | -60.12M | -55.23M | -70.07M |
Investments In Property Plant And Equipment | -7K | -35K | -479K | -708K | -894K | -217K | 0 | -51K | -4K | -15K |
Acquisitions Net | 0 | -53.72M | -7.37M | -25.41M | 105.4M | -24.53M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 49.14M | 53.69M | 6.89M | 24.70M | -106.29M | 24.31M | -44.32M | -10.07M | 9.97M | -10.05M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 52.32M | 3.13M | 74.50M | 220K | 70.15M | 4.21M | 0 | 43.07M |
Payments for dividends | -11.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -40K | 0 | 0 | 0 | 0 | -267K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -11.86M | -40K | 49.05M | 3.46M | 74.77M | 1.38M | 70.48M | 4.21M | 0 | 43.07M |
Net Change In Cash | -13.20M | 1.16M | 7.19M | -3.78M | 2.74M | -3.71M | 4.85M | -2.37M | -7.88M | 4.94M |
Cash at end of period | 3.70M | 16.90M | 15.74M | 8.54M | 12.33M | 9.59M | 13.30M | 8.45M | 10.83M | 18.72M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |